Keyphrases
Acute Lymphoblastic Leukemia
77%
Bone Marrow Transplantation
47%
Childhood Acute Lymphoblastic Leukemia
38%
Neuroblastoma
34%
Bone Marrow
31%
Dutch
26%
Survivors
25%
Pediatric Oncology
24%
BTG1
24%
Gene Therapy
23%
IKZF1 Deletion
23%
Allogeneic Bone Marrow Transplantation
22%
Children with Cancer
21%
Minimal Residual Disease
21%
BCP-ALL
20%
Macrophages
19%
Pediatric Acute Lymphoblastic Leukemia
18%
Leukemia
17%
Pediatric Cancer Patients
17%
Working Diagnosis
17%
Tumor
17%
Quality of Life
17%
IKZF1
17%
Transplantation
16%
Chemotherapy
16%
Twitcher Mouse
15%
T Cells
14%
Ganciclovir
14%
Methotrexate
13%
Event-free Survival
13%
High Risk
13%
Oncology
13%
Herpes Simplex Virus Thymidine Kinase
13%
Thymidine Kinase Gene
13%
Childhood Cancer Survivors
13%
Childhood B-cell Precursor Acute Lymphoblastic Leukemia
13%
Gene Transfer
13%
Osteosarcoma
13%
Relapsed or Refractory Acute Myeloid Leukemia
13%
ETV6-RUNX1
12%
Lysosomal Storage Disease
12%
Hemopoietic Stem Cells
12%
Bone Marrow Cells
12%
Stem Cell Transplantation
12%
Genomic Profiling
12%
Healthy Controls
12%
Pediatric Patients
11%
Chimeric Antigen Receptor T-cell Therapy
11%
Tumor Suppressor
11%
Adenosine Deaminase Deficiency
11%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Precursor
36%
B Cell
33%
Pediatrics
33%
Bone Marrow Transplantation
29%
Ganglioneuroblastoma
25%
Disease
25%
Neoplasm
21%
Minimal Residual Disease
21%
Malignant Neoplasm
21%
Childhood Cancer
20%
Quality of Life
19%
Allogenic Bone Marrow Transplantation
18%
Leukemia
15%
Chemotherapy
15%
Immunotherapy
15%
Bone Cancer
15%
Event Free Survival
12%
Pediatric Cancer
12%
Oncology
12%
Central Nervous System
12%
Lysosomal Storage Disease
11%
Survival Rate
11%
Gene Expression
10%
T Cell
10%
Overall Survival
9%
Echocardiography
8%
Osteosarcoma
8%
Cancer
8%
Vorinostat
8%
Pediatrics Patient
8%
Solid Malignant Neoplasm
8%
Patient-Reported Outcome
7%
Lipoprotein Metabolism
7%
Gene Therapy
7%
Atherosclerosis
7%
LDL Receptor
7%
Anthracycline
7%
Germ Cell
7%
Adolescence
6%
Neuroblastoma Cell
6%
Hazard Ratio
6%
Neurologic Disease
6%
Brain Natriuretic Peptide
6%
Lymphocyte
6%
Clinical Trial
5%
Ganciclovir
5%
Histone Deacetylase Inhibitor
5%
Intracranial Tumor
5%
Metastatic Carcinoma
5%